Mark Cuban’s Pharmacy Teams up With Cancer Health App

The Mark Cuban Cost Plus Drug Company and OncoPower have teamed up to launch Medication Savings Suite. The new offering integrates Cost Plus Drugs with OncoPower’s Pill Reminder tool, which will provide an alert to patients about lower cost alternatives. OncoPower, launched by the digital health company, Witty Health, in September 2022 and is a free app for patients with cancer. Members will be able to place orders in-app through Cost Plus Drugs online pharmacy to have drugs delivered to their homes.

Alex Oshmyansky, M.D.

“We are excited to work with OncoPower to bring lower prescription drug prices to consumers,” Alex Oshmyansky, M.D., chief executive officer of Mark Cuban Cost Plus Drug Company, said in a press release. “Cost Plus Drugs and OncoPower share a common goal of providing consumers the lowest possible price for their prescription medication. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.”

OncoPower is both an app and website with a social media style format in which patients and providers support one another, patients have access to professionals such as registered dietitians and behavioral therapists, cancer education and meditation content. OncoPower facilitates matching patients with clinical trials and helps reduce barriers for patients in accessing new oncology drugs and therapies. It has more than 5,000 users and more than 400 member oncologists.

A spokesperson said there is no cost for patients to join. They can use the pill reminder tool to log medication regimens to get automated reminders, access patient videos on side effects from those medications, can reach out to one of our oncologists or nurses for assistance, have a head start on identifying clinical trials based on current treatments, and now get transparent pricing information all in one place.

At the time of its launch, OncoPower founders said they wanted to create continuity of care while also delivering that care at a cheaper price on a greater scale. Cost Plus Drugs launched a year ago and now offers more than 1,000 drugs. Over the last year, Cost Plus Drugs has developed partnership with health plans, managed-care organizations, PBMs and self-insured employers.

So far, just a handful of cancer drugs are offered through OncoPower and include the generics of Gleevec (imatinib), Zytiga (abiraterone), Arimdex (anastrozole) and Nolvadex (tamoxifen).

"OncoPower and Cost Plus Drugs are working to add more cancer medications, and it will remain an ongoing endeavor that taps into the feedback of the OncoPower community," the spokeperson said. "Cancer patients often rely on supportive care drugs, such as anti-nausea meds or steroids, that are currently offered on the Cost Plus Drugs site. Typically two-thirds of cancer patients are senior citizens and invariably use other medications for comorbid conditions like diabetes, hypertension, pain, asthma, and kidney diseases alongside their cancer medications."

This story has been updated to include additional information from OncoPower.